Patents by Inventor Chris Fegan

Chris Fegan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer
    Patent number: 11287416
    Abstract: The invention relates to cancer, and in particular to novel pharmaceutical compositions, therapies and methods for treating, preventing or ameliorating cancer, and especially metastatic disease. The invention also relates to diagnostic and prognostic methods for cancer and metastatic disease, and biomarkers for these conditions.
    Type: Grant
    Filed: January 30, 2017
    Date of Patent: March 29, 2022
    Assignee: NEURO-BIO LTD
    Inventors: Susan Adele Greenfield, Henry Tu, Paul Morrill, Sara Garcia-Rates, Chris Pepper, Chris Fegan
  • CANCER
    Publication number: 20190025289
    Abstract: The invention relates to cancer, and in particular to novel pharmaceutical compositions, therapies and methods for treating, preventing or ameliorating cancer, and especially metastatic disease. The invention also relates to diagnostic and prognostic methods for cancer and metastatic disease, and biomarkers for these conditions.
    Type: Application
    Filed: January 30, 2017
    Publication date: January 24, 2019
    Applicant: NEURO-BIO LTD
    Inventors: Susan GREENFIELD, Henry TU, Paul MORRILL, Sara GARCIA-RATES, Chris PEPPER, Chris FEGAN
  • Method and apparatus for notifying a user of separation from a mobile device
    Patent number: 8068847
    Abstract: Disclosed herein is a system and method for notifying a person that they have become separated from their mobile communication device. A comparison between location information for the device and presence information for the person is used to determine whether or not a separation exists. Certain corrective actions are possible in order to mitigate the consequences of the separation. A separation may be allowed to exist within a certain maximum allowable distance of separation without the system or method notifying the person.
    Type: Grant
    Filed: August 9, 2006
    Date of Patent: November 29, 2011
    Assignee: Avaya Inc.
    Inventors: Chris Fegan, Katherine Hamilton, Neil Hepworth, Lawrence Ongud Opiyo
  • Chronic lymphocytic leukaemia
    Patent number: 7709199
    Abstract: The invention relates to materials and methods for evaluating the prognosis of a patient presenting with chronic myelogenous leukaemia (CLL) and for CLL therapy.
    Type: Grant
    Filed: September 22, 2006
    Date of Patent: May 4, 2010
    Assignee: University College Cardiff Consultants Limited
    Inventors: Chris Pepper, Paul Brennan, Naomi Price-Lloyd, Janet E. Williams, Jeff D. Griffiths, Chris Fegan
  • Chronic lymphocytic leukaemia
    Publication number: 20080026383
    Abstract: The invention relates to materials and methods for evaluating the prognosis of a patient presenting with chronic myelogenous leukaemia (CLL) and for CLL therapy.
    Type: Application
    Filed: September 22, 2006
    Publication date: January 31, 2008
    Applicant: UNIVERSITY COLLEGE CARDIFF
    Inventors: Chris Pepper, Paul Brennan, Naomi Price-Lloyd, Janet E. Williams, Jeff D. Griffiths, Chris Fegan